Advertisement

Gelsolin and Disease

  • Leslie D. Burtnick
  • Robert C. Robinson
Part of the Protein Reviews book series (PRON, volume 8)

Gelsolin is a multifunctional regulator of actin filament formation and disassembly (reviewed in Sun et al. 1999; Kwiatkowski 1999; McGough et al. 2003; Silacci et al. 2004). It can bind to the side of an F-actin filament, sever that filament in a nonhydrolytic manner, and cap the fast growing end of one of the resultant fragments. Uncapping can be induced through the binding of specific phospholipids (see chapter by dos Remedios), for example, phosphatidylinositol 4,5-bisphosphate (PIP2), to expose the fast growing end of a prenucleated filament.

Keywords

Actin Monomer Finnish Type Plasma Gelsolin Actin Regulatory Protein Familial Amyloidosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Afify, A. M. and Werness, B. A. 1998. Decreased expression of the actin-binding protein gelsolin in endometrial and ovarian adeno-carcinomas. Appl. Immunohistochem. 6, 30-34.CrossRefGoogle Scholar
  2. Ahn, J. S., Jang, I. -S., Kim, D. -I., Cho, K. A., Park, Y. H., Kim, K., Kwak, C. S. and Park, S. C. 2003. Aging-associated increase of gelsolin for apoptosis resistance. Biochem. Biophys. Res. Commun. 312, 1335-1341.CrossRefPubMedGoogle Scholar
  3. Asch, H. L., Head, K., Dong, Y., Natoli, F., Winston, J. S., Connolly, J. L. and Asch, B. B. 1996. Widespread loss of gelsolin in breast cancers of humans, mice and rats. Cancer Res. 56, 4841-4845.PubMedGoogle Scholar
  4. Azuma, T., Koths, K., Flanagan, L. and Kwiatkowski, D. 2000. Gelsolin in complex with phosphatidylinositol 4,5-bisphosphate inhibits caspase-3 and -9 to retard apoptotic progression. J. Biol. Chem. 275, 3761-3766.CrossRefPubMedGoogle Scholar
  5. Bucki, R., Georges, P. C., Espinassous, Q., Funaki, M., Pastore, J. J., Chaby, R. and Janmey, P. A. 2005. Inactivation of endotoxin by human plasma gelsolin. Biochemistry 44, 9590-9597.CrossRefPubMedGoogle Scholar
  6. Burtnick, L. D., Koepf, E. K., Grimes, J. M., Jones, E. Y., Stuart, D. I., McLaughlin, P. J. and Robinson, R. C. 1997. The crystal structure of plasma gelsolin: Implications for actin severing, capping and nucleation. Cell 90, 661-670.CrossRefPubMedGoogle Scholar
  7. Burtnick, L. D., Robinson, R. C. and Choe, S. 2001. Structure and function of gel- solin. Results Probl. Cell Differ. 32, 201-211.Google Scholar
  8. Burtnick, L. D., Urosev, D., Irobi, E., Narayan, K. and Robinson, R. C. 2004. Structure of the N-terminal half of gelsolin bound to actin: Roles in severing, apoptosis and FAF. EMBO J. 23, 2713-2722.CrossRefPubMedGoogle Scholar
  9. Chellaiah, M., Kizer, N., Silva, M., Alvarez, U., Kwiatkowski, D. and Hruska, K. A. 2000. Gelsolin deficiency blocks podosome assembly and produces increased bone mass and strength. J. Cell Biol. 148, 665-678.CrossRefPubMedGoogle Scholar
  10. Chen, C. -D., Huff, M., Matteson, J., Page, L., Phillips, R., Kelly, J. W. and Balch, W. E. 2001. Furin initiates gelsolin familial amyloidosis in the Golgi through a defect in Ca2+ stabilization. EMBO J. 20, 6277-6287.CrossRefPubMedGoogle Scholar
  11. Choe, H., Burtnick, L. D., Mejillano, M., Yin, H. L., Robinson, R. C. and Choe, S. 2002. The calcium activation of gelsolin: Insights from the 3 Å structure of the G4-G6/actin complex. J. Mol. Biol. 324, 691-702.CrossRefPubMedGoogle Scholar
  12. Christofidou-Solomidou, M., Scherpereel, A., Solomides, C. C., Christie, J. D., Stossel, T. P., Goelz, S. and DiNubile, M. J. 2002. Recombinant plasma gelsolin diminishes the acute inflammatory response to hyperoxia in mice. J. Investig. Med. 50, 54-60.CrossRefPubMedGoogle Scholar
  13. Crowley, M. R., Head, K. L., Kwiatkowski, D., Asch, H. and Asch, B. 2000. The mouse mammary gland requires the actin-binding protein gelsolin for proper ductal morphogenesis. Dev. Biol. 225, 407-423.CrossRefPubMedGoogle Scholar
  14. Cunningham, C. C., Stossel, T. P. and Kwiatkowski, D. J. 1991. Enhanced mobility in NIH 3T3 fibroblasts that overexpress gelsolin. Science 251, 1233-1236.CrossRefPubMedGoogle Scholar
  15. Dahl, B., Schiodt, F. V., Ott, P., Gvozdenovic, R., Yin, H. L. and Lee, W. M. 1999. Plasma gelsolin is reduced in trauma patients. Shock 12, 102-104.CrossRefPubMedGoogle Scholar
  16. Dahl, B., Schiodt, F. V., Ott, P., Kiaer, T., Bondesen, S. and Tygstrup, N. 1998. GcGlobulin in the early course of multi-trauma. Crit. Care Med. 26, 285-289.CrossRefPubMedGoogle Scholar
  17. Erukhimov, J. A., Tang, Z. -L., Johnson, B. A., Donahoe, M. P., Razzack, J. A., Gibson, K. F., Lee, W. M., Wasserloos, K. J., Watkins, S. A. and Pitt, B. R. 2000. Actin-containing sera from patients with adult respiratory distress syndrome are toxic to sheep pulmonary endothelial cells. Am. J. Respir. Crit. Care Med. 162, 288-294.PubMedGoogle Scholar
  18. Fujita, H., Okada, F., Hamada, J. -I., Hosokawa, M., Moriuchi, T., Koya, R. C. and Kuzumaki, N. 2001. Gelsolin functions as a metastasis suppressor in B16-BL6 mouse melanoma cells and requirement of the carboxyl-terminus for its effect. Int. J. Cancer 93, 773-780.CrossRefPubMedGoogle Scholar
  19. Furuuchi, K., Fujita, H., Tanaka, M., Shinohara, N., Senmaru, N., Ogiso, Y., Moriya, S., Hamada, M., Kato, H. and Kuzumaki, N. 1996. Gelsolin as a suppressor of malignant phenotype in human colon cancer. Tumor Target 2, 277-283.Google Scholar
  20. Gourlay, C. W. and Ayscough, K. R. 2005. The actin cytoskeleton: A key regulator of apoptosis and ageing? Nat. Rev. Mol. Cell Biol. 6, 583-589.CrossRefPubMedGoogle Scholar
  21. Huff, M. E., Page, L. J., Balch, W. E. and Kelly, J. W. 2003. Gelsolin domain 2 Ca2+ affinity determines susceptibility to furin proteolysis and familial amyloidosis of Finnish type. J. Mol. Biol. 334, 119-127.CrossRefPubMedGoogle Scholar
  22. Kangas, H., Paunio, T., Kalkkinen, N., Jalanko, A. and Peltonen, L. 1996. In vitro expression analysis shows that the secretory form of gelsolin is the sole source of amyloid in gelsolin-related amyloidosis. Hum. Mol. Genet. 5, 1237-1243.CrossRefPubMedGoogle Scholar
  23. Kazmirski, S. L., Isaacson, R. L., An, C., Buckle, A., Johnson, C. M., Daggett, V. and Fersht, A. R. 2002. Loss of a metal-binding site in gelsolin leads to familial amyloidosis-Finnish type. Nat. Struct. Biol. 9, 112-116.CrossRefPubMedGoogle Scholar
  24. Kinosian, H. J., Newman, J., Lincoln, B., Selden, L. A., Gershman, L. C. and Estes, J. E. 1998. Ca2+ regulation of gelsolin activity: Binding and severing of F-actin. Biophys. J. 75, 3101-3109.CrossRefPubMedGoogle Scholar
  25. Kiselar, J. G., Janmey, P. A., Almo, S. and Chance, M. R. 2003. Visualizing the Ca2+dependent activation of gelsolin by using synchrotron footprinting. Proc. Natl Acad. Sci. USA 100, 3942-3947.CrossRefPubMedGoogle Scholar
  26. Klampfer, L., Huang, J., Sasazuki, T., Shirasawa, S. and Augenlicht, L. 2004. Oncogenic Ras promotes butyrate-induced apoptosis through inhibition of gelsolin expression. J. Biol. Chem. 279, 36680-36688.CrossRefPubMedGoogle Scholar
  27. Koepf, E. K., Hewitt, J., Vo, H., MacGillivray, R. T. A. and Burtnick, L. D. 1998. Equus caballus gelsolin: cDNA sequence and protein structural implications. Eur. J. Biochem. 251, 613-621.CrossRefPubMedGoogle Scholar
  28. Kothakota, S., Azuma, T., Reinhard, C., Klippel, A., Tang, J., Chu, K., McGarry, T. J., Kirschner, M. W., Koths, K., Kwiatkowski, D. J. and Williams, L. T. 1997. Caspase3-generated fragment of gelsolin: Effector of morphological change in apoptosis. Science 278, 294-298.CrossRefPubMedGoogle Scholar
  29. Koya, R. C., Fujita, H., Shimizu, S., Ohtsu, M., Takimoto, M., Tsujimoto, Y. and Kuzumaki, N. 2000. Gelsolin inhibits apoptosis by blocking mitochondrial membrane potential loss and cytochrome c release. J. Biol. Chem. 275, 15343-15349.CrossRefPubMedGoogle Scholar
  30. Kusano, H., Shimizu, S., Koya, R. C., Fujita, H., Kamada, S., Kuzumaki, N. and Tsujimoto, Y. 2000. Human gelsolin prevents apoptosis by inhibiting apoptotic mitochondrial changes via closing VDAC. Oncogene 19, 4807-4814.CrossRefPubMedGoogle Scholar
  31. Kwiatkowski, D. J. 1999. Functions of gelsolin: Motility, signaling, apoptosis, cancer. Curr. Opin. Cell Biol. 11, 103-108.CrossRefPubMedGoogle Scholar
  32. Kwiatkowski, D. J., Stossel, T. P., Orkin, S. H., Mole, J. E., Colten, H. and Yin, H. L. 1986. Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin binding domain. Nature 323, 455-458.CrossRefPubMedGoogle Scholar
  33. Lee, H. -K., Driscoll, D., Asch, H., Asch, B. and Zhang, P. J. 1999. Downregulated gelsolin expression in hyperplastic and neoplastic lesions of the prostate. Prostate 40,14-19.CrossRefPubMedGoogle Scholar
  34. Lee, W. M. and Galbraith, R. M. 1992. The extracellular actin-scavenger system and actin toxicity. N. Engl. J. Med. 326, 1335-1341.PubMedCrossRefGoogle Scholar
  35. Lind, S. E., Smith, C. J., Janmey, P. A. and Stossel, T. P. 1986. Role of plasma gelsolin and the vitamin D-binding protein in clearing actin from the circulation. J. Clin. Invest. 78, 736-742.CrossRefPubMedGoogle Scholar
  36. Lu, M., Witke, W., Kwiatkowski, D. J. and Kosik, K. S. 1997. Delayed retraction of filopodia in gelsolin null mice. J. Cell Biol. 138, 1279-1287.CrossRefPubMedGoogle Scholar
  37. Lueck, A., Yin, H. L., Kwiatkowski, D. J. and Allen, P. G. 2000. Calcium regulation of gelsolin and adseverin: A natural test of the helix latch hypothesis. Biochemistry 39,5274-5279.CrossRefPubMedGoogle Scholar
  38. Maury, C. P. J., Alli, K. and Baumann, M. 1990. Finnish hereditary amyloidosis. Amino acid sequence homology between the amyloid fibril protein and human plasma gelsolin. FEBS Lett. 260, 85-87.CrossRefPubMedGoogle Scholar
  39. Maury, C. P. J., Liljeström, M., Boysen, G., Törnroth, T., de la Chapelle, A. and Nurmiaho-Lassila, E. -L. 2000. Danish type gelsolin related amyloidosis: 654G-T mutation is associated with a disease pathogenetically and clinically similar to that caused by the 654G-A mutation (familial amyloidosis of the Finnish type). J. Clin. Pathol. 53, 95-99.CrossRefPubMedGoogle Scholar
  40. McGhie, E. J., Hayward, R. D. and Koronakis, V. 2004. Control of actin turnover by a salmonella invasion protein. Mol. Cell 13, 497-510.CrossRefPubMedGoogle Scholar
  41. McGough, A., Staiger, C. J., Mina, J. -K. and Simonetti, K. D. 2003. The gelsolin family of actin regulatory proteins: Modular structures, versatile functions. FEBS Lett. 552, 75-81.CrossRefPubMedGoogle Scholar
  42. Mielnicki, L. M., Ying, A. M., Head, K. L., Asch, H. and Asch, B. 1999. Epigenetic regulation of gelsolin expression in human breast cancer cells. Exp. Cell Res. 249, 161-176.CrossRefPubMedGoogle Scholar
  43. Moriya, S., Yanagihara, K., Fujita, H. and Kuzumaki, N. 1994. Differential expression of hsp90, gelsolin and GST-p in human gastric carcinoma cell lines. Int. J. Oncol. 5, 1347-1351.Google Scholar
  44. Mounzer, K. C., Moncure, M., Smith, Y. R. and DiNubile, M. J. 1999. Relationship of admission plasma gelsolin levels to clinical outcomes in patients after major trauma. Am. J. Respir. Crit. Care Med. 160, 1673-1681.PubMedGoogle Scholar
  45. Ohtsu, M., Sakai, N., Fujita, H., Kashiwagi, M., Gasa, S., Shimizu, S., Eguchi, Y., Tsujimoto, Y., Sakiyama, Y., Kobayashi, K. and Kuzumaki, N. 1997. Inhibition of apoptosis by the actin-regulatory protein gelsolin. EMBO J. 16, 4650-4656.CrossRefPubMedGoogle Scholar
  46. Page, L. J., Suk, J. Y., Huff, M. E., Lim, H. -J., Venable, J., Yates, J., III, Kelly, J. W., and Balch, W. 2005. Metalloendoprotease cleavage triggers gelsolin amyloidogenesis. EMBO J. 24, 4124-4132.CrossRefPubMedGoogle Scholar
  47. Pope, B. J., Gooch, J. T. and Weeds, A. G. 1997. Probing the effects of calcium on gelsolin. Biochemistry 36, 15848-15855.CrossRefPubMedGoogle Scholar
  48. Posey, S. C., Martelli, M. P., Azuma, T., Kwiatkowski, D. J. and Bierer, B. E. 2000. Failure of gelsolin overexpression to regulate lymphocyte apoptosis. Blood 95, 3483-3488.PubMedGoogle Scholar
  49. Ray, I., Chauhan, A., Wegiel, J. and Chauhan, V. P. S. 2000. Gelsolin inhibits the fibrillization of amyloid beta-protein, and also defibrillizes its preformed fibrils. Brain Res. 853, 344-351.CrossRefPubMedGoogle Scholar
  50. Robinson, R. C., Mejillano, M., Le, V. P., Burtnick, L. D., Yin, H. L. and Choe, S. 1999. Domain movement in gelsolin: A calcium-activated switch. Science 286, 1939-1942.CrossRefPubMedGoogle Scholar
  51. Rothenbach, P. A., Dahl, B., Schwartz, J. J., O’Keefe, G. E., Yamamoto, M., Lee, W. M., Horton, J. W., Yin, H. L. and Turnage, R. H. 2004. Recombinant plasma gelsolin infusion attenuates burn-induced pulmonary microvascular dysfunction. J. Appl. Physiol. 96, 25-31.CrossRefPubMedGoogle Scholar
  52. Sacchettini, J. C. and Kelly, J. W. 2002. Therapeutic strategies for human amyloid diseases. Nat. Rev. Drug Discov. 1, 267-275.CrossRefPubMedGoogle Scholar
  53. Safer, D. 1989. An electrophoretic procedure for detecting proteins that bind actin monomers. Anal. Biochem. 178, 32-37.CrossRefPubMedGoogle Scholar
  54. Sagawa, N., Fujita, H., Banno, Y., Nozawa, Y., Katoh, H. and Kuzumaki, N. 2003. Gelsolin suppresses tumourigenicity through inhibiting PKC activation in human lung cancer cell line, PC10. Br. J. Cancer 88, 606-612.CrossRefPubMedGoogle Scholar
  55. Sakurai, N. and Utsumi, T. 2006. Posttranslational N-myristoylation is required for the anti-apoptotic activity of human tGelsolin, the C-terminal caspase cleavage product of human gelsolin. J. Biol. Chem. 281, 14288-14295.CrossRefPubMedGoogle Scholar
  56. Shieh, D. G. J., Sugarbaker, D. J., Herndon, J. and Kwiatdowski, D. J. 1999. Motility as a prognostic factor in non-small lung cancer: Role of gelsolin expression. Cancer 85,47-57.CrossRefPubMedGoogle Scholar
  57. Silacci, P., Mazzolai, L., Gauci, C., Stergiopulos, N., Yin, H. L. and Hayoz, D. 2004. Gelsolin superfamily proteins: Key regulators of cellular functions. Cell. Mol. Life Sci. 61, 2614-2623.CrossRefPubMedGoogle Scholar
  58. Sun, H. Q., Yamamoto, M., Mejillano, M. and Yin, H. L. 1999. Gelsolin, a multifunctional actin regulatory protein. J. Biol. Chem. 274, 33179-33182.CrossRefPubMedGoogle Scholar
  59. Tanaka, M., Müllauer, L., Ogiso, Y., Fujita, H., Moriya, S., Furuuchi, K., Harabayashi, T., Shinohara, N., Koyanagi, T. and Kuzumaki, N. 1995. Gelsolin: A candidate for suppressor of human bladder cancer. Cancer Res. 55, 3228-3232.PubMedGoogle Scholar
  60. Thomas, G. 2002. Furin at the cutting edge: From protein traffic to embryogenesis and disease. Nat. Rev. Mol. Cell Biol. 3, 753-766.CrossRefPubMedGoogle Scholar
  61. Thor, A. D., Edgerton, S. M., Liu, S., Moore, D. H., II. and Kwiatkowski, D. J. 2001. Gelsolin as a negative prognostic factor and effector of motility in erbB-2-positive epidermal growth factor receptor-positive breast cancers. Clin. Cancer Res. 7, 2415-2424.PubMedGoogle Scholar
  62. Van Baelen, H., Bouillon, R. and De Moor, P. 1980. Vitamin D-binding protein (Gc-globulin) binds actin. J. Biol. Chem. 255, 2270-2272.PubMedGoogle Scholar
  63. Vasconcellos, C. A., Allen, P. G., Wohl, M. E., Drazen, J. M., Janmey, P. A. and Stossel, T. P. 1994. Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin. Science 263, 969-971.CrossRefPubMedGoogle Scholar
  64. Way, M. and Weeds, A. G. 1988. Nucleotide sequence of pig plasma gelsolin. Comparison of protein sequence with human gelsolin and other actin-severing proteins shows strong homologies and evidence for large internal repeats. J. Mol. Biol. 203,1127-1133.CrossRefPubMedGoogle Scholar
  65. Wen, D., Corina, K., Chow, E., Miller, S., Janmey, P. and Pepinsky, R. 1996. The plasma and cytoplasmic forms of human gelsolin differ in disulfide structure. Biochemistry 35, 9700-9709.CrossRefPubMedGoogle Scholar
  66. Witke, W., Sharpe, A. H., Hartwig, J. H., Azuma, T., Stossel, T. P. and Kwiatkowski, D. J. 1995. Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking gelsolin. Cell 81, 41-51.CrossRefPubMedGoogle Scholar
  67. Yang, J., Ramnath, N., Moysich, K. B., Asch, H. L., Swede, H., Alrawi, S. J., Huberman, J., Geradts, J., Brooks, J. S. J. and Tan, D. 2006. Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer. BMC Cancer 6,203.CrossRefPubMedGoogle Scholar
  68. Zapun, A., Grammatyka, S., Deral, G. and Vernet, T. 2000. Calcium-dependent conformational stability of modules 1 and 2 of human gelsolin. Biochem. J. 350 (Part 3),873-888.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Leslie D. Burtnick
    • 1
  • Robert C. Robinson
    • 2
  1. 1.Chemistry Department and Centre for Blood Research, Life Sciences InstituteUniversity of British ColumbiaVancouverCanada
  2. 2.Institute of Molecular and Cell Biology ProteosSingapore

Personalised recommendations